Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
, a physician-scientist founded health and wellness company, today announced it has raised a total of $14.5 million , including a recently concluded $8 million Series A round supported by major shareholders Sororibus Capital and Biostack Ventures
The first ingredient, tirzepatide , is a dual GIP/GLP-1 receptor agonist originally developed by Eli Lilly and approved by the FDA under the brand names Mounjaro (for type 2 diabetes) and Zepbound (for chronic weight management)
doi: 10.1007/s00109-014-1170-1 173 CsakTGanzMPespisaJKodysKDolganiucASzaboG
Millions of regular folks have followed suit
US$ 22.04
US$ 22.25
US$ 22.43
US$ 22.29
US$ 24.86
US$ 20.09
US$ 27.26
